Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence
Baron-Papillon
President (Sanofi)
Juan Carlos
Jaramillo
Vice-President (Valneva)
Deborah
Scarano
Treasurer (Pfizer)
Andreas
Potthoff
(Abbott)
Lorenzo
Wittum
(AstraZeneca)
Sharon
McHale
(CSL Seqirus)
Guillermo
De Juan Echávarri
(GSK)
Alexander
Meier
(Moderna)
Nicoletta
Luppi
(MSD)
Kelly
Cappio
(Novavax)

Executive office

Sibilia
Quilici
Executive Director
Laurent
Louette
Director, Public Affairs & Country Liaison
Anna
Czwarno
Director, Regulatory and R&D
Charlotte
Vernhes
Director, Scientific and Medical Affairs
Anna
Vicere
Associate Director, Public Affairs & Access Policy
Andreea
Iordache
Manager, Science & Regulatory Affairs
Polina
Zoteva
Communications Lead
Anne
Meynaerts
Administrative Assistant

Working Group Chairs